Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAGBiotechnology
Healthcare
$39.15 +8.79%
+$2.32 today
- Market cap
- $1.83B
- Beta
- 0.00
52W Low $23.00High $36.61
Volume 0.30M
Average 0.34M
Price history
Hemab Therapeutics Holdings, Inc. Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+15.15%
Period high
$54.94
Period low
$24.98
Latest
$39.15
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| SC 13G/A | Nov 6, 2026 | Nov 6, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 3 | Sep 25, 2026 | Sep 25, 2026 | |
| 8-K | Sep 24, 2026 | Sep 24, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 12, 2026 | Aug 12, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 | |
| SC 13G | Aug 6, 2026 | Aug 6, 2026 | |
| SC 13G | Aug 5, 2026 | Aug 5, 2026 | |
| 4 | Jun 17, 2026 | Jun 17, 2026 |
Competitors
Who does Hemab Therapeutics Holdings, Inc. Common Stock compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about COAG's filings, answered from its disclosures.
What is the latest COAG filing?
The latest filing shown is 8-K dated Nov 10, 2026.
How many recent filings does COAG have?
Intrinsic Alpha currently shows 20 recent filings for COAG.
Continue the stock analysis
Jump to another research area for this company.